Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Luteolin reduces Alzheimer's disease pathologies induced by traumatic brain injury.

Sawmiller D, Li S, Shahaduzzaman M, Smith AJ, Obregon D, Giunta B, Borlongan CV, Sanberg PR, Tan J.

Int J Mol Sci. 2014 Jan 9;15(1):895-904. doi: 10.3390/ijms15010895.

2.

Lithium reduces BACE1 overexpression, β amyloid accumulation, and spatial learning deficits in mice with traumatic brain injury.

Yu F, Zhang Y, Chuang DM.

J Neurotrauma. 2012 Sep;29(13):2342-51. doi: 10.1089/neu.2012.2449. Epub 2012 Jul 2.

3.

Altered Neuroinflammation and Behavior after Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease.

Kokiko-Cochran O, Ransohoff L, Veenstra M, Lee S, Saber M, Sikora M, Teknipp R, Xu G, Bemiller S, Wilson G, Crish S, Bhaskar K, Lee YS, Ransohoff RM, Lamb BT.

J Neurotrauma. 2016 Apr 1;33(7):625-40. doi: 10.1089/neu.2015.3970. Epub 2015 Nov 23.

4.

Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.

Bates K, Vink R, Martins R, Harvey A.

Neurobiol Aging. 2014 Jun;35(6):1345-51. doi: 10.1016/j.neurobiolaging.2013.11.020. Epub 2013 Nov 27.

PMID:
24360504
5.

Distinct temporal and anatomical distributions of amyloid-β and tau abnormalities following controlled cortical impact in transgenic mice.

Tran HT, Sanchez L, Esparza TJ, Brody DL.

PLoS One. 2011;6(9):e25475. doi: 10.1371/journal.pone.0025475. Epub 2011 Sep 29.

6.

Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).

Crawford FC, Wood M, Ferguson S, Mathura VS, Faza B, Wilson S, Fan T, O'Steen B, Ait-Ghezala G, Hayes R, Mullan MJ.

Brain Res. 2007 Dec 14;1185:45-58. Epub 2007 Sep 25.

PMID:
17961517
7.

Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model.

Castillo-Carranza DL, Guerrero-Muñoz MJ, Sengupta U, Hernandez C, Barrett AD, Dineley K, Kayed R.

J Neurosci. 2015 Mar 25;35(12):4857-68. doi: 10.1523/JNEUROSCI.4989-14.2015.

8.

Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging.

Nakagawa Y, Nakamura M, McIntosh TK, Rodriguez A, Berlin JA, Smith DH, Saatman KE, Raghupathi R, Clemens J, Saido TC, Schmidt ML, Lee VM, Trojanowski JQ.

J Comp Neurol. 1999 Aug 30;411(3):390-8.

PMID:
10413774
9.

Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice.

Tran HT, Sanchez L, Brody DL.

J Neuropathol Exp Neurol. 2012 Feb;71(2):116-29. doi: 10.1097/NEN.0b013e3182456aed.

10.

Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.

Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, Lee VM, Clark RS, Marion DW, Wisniewski SR, DeKosky ST.

Exp Neurol. 2004 Nov;190(1):192-203.

PMID:
15473992
11.

Posttraumatic administration of luteolin protects mice from traumatic brain injury: implication of autophagy and inflammation.

Xu J, Wang H, Lu X, Ding K, Zhang L, He J, Wei W, Wu Y.

Brain Res. 2014 Sep 25;1582:237-46. doi: 10.1016/j.brainres.2014.07.042. Epub 2014 Aug 2.

PMID:
25093609
12.

Glycogen synthase kinase-3 regulates production of amyloid-β peptides and tau phosphorylation in diabetic rat brain.

Qu ZS, Li L, Sun XJ, Zhao YW, Zhang J, Geng Z, Fu JL, Ren QG.

ScientificWorldJournal. 2014;2014:878123. doi: 10.1155/2014/878123. Epub 2014 Apr 3.

13.

Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

Uryu K, Laurer H, McIntosh T, Praticò D, Martinez D, Leight S, Lee VM, Trojanowski JQ.

J Neurosci. 2002 Jan 15;22(2):446-54.

14.

Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice.

Ordóñez-Gutiérrez L, Re F, Bereczki E, Ioja E, Gregori M, Andersen AJ, Antón M, Moghimi SM, Pei JJ, Masserini M, Wandosell F.

Nanomedicine. 2015 Feb;11(2):421-30. doi: 10.1016/j.nano.2014.09.015. Epub 2014 Nov 14.

PMID:
25461285
15.

Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.

Hartman RE, Laurer H, Longhi L, Bales KR, Paul SM, McIntosh TK, Holtzman DM.

J Neurosci. 2002 Dec 1;22(23):10083-7.

16.

Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model.

Washington PM, Morffy N, Parsadanian M, Zapple DN, Burns MP.

J Neurotrauma. 2014 Jan 1;31(1):125-34. doi: 10.1089/neu.2013.3017. Epub 2013 Dec 10.

17.

Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.

Cao C, Cirrito JR, Lin X, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, Arendash GW, Holtzman DM, Potter H.

J Alzheimers Dis. 2009;17(3):681-97. doi: 10.3233/JAD-2009-1071. Erratum in: J Alzheimers Dis. 2009 Nov;18(3):727. Wang, Lilly [corrected to Wang, Li]..

18.

Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.

Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM.

FASEB J. 2004 May;18(7):902-4. Epub 2004 Mar 19.

PMID:
15033922
19.

Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.

Bitel CL, Kasinathan C, Kaswala RH, Klein WL, Frederikse PH.

J Alzheimers Dis. 2012;32(2):291-305. doi: 10.3233/JAD-2012-120571.

PMID:
22785400
20.

Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.

Lee M, McGeer E, McGeer PL.

Neurobiol Aging. 2015 Jan;36(1):42-52. doi: 10.1016/j.neurobiolaging.2014.07.024. Epub 2014 Jul 24.

PMID:
25169677

Supplemental Content

Support Center